DPT Laboratories

What DPT Laboratories does

DPT Laboratories, Ltd. is a U.S.-based contract development and manufacturing organization (CDMO) founded in 1938 and headquartered at 307 E. Josephine St., San Antonio, Texas. The company is a wholly-owned subsidiary of Viatris Inc. (formerly Mylan N.V.) and specializes exclusively in semi-solid and liquid pharmaceutical dosage forms — aerosols, creams, emulsions, gels, lotions, ointments, solutions, and suspensions.

DPT operates an integrated service model covering the full pharmaceutical development lifecycle under one roof: pre-formulation (API characterization, solubility, excipient compatibility), drug formulation, analytical method development and validation (HPLC, UPLC, GC/MS, LC/MS/MS, spectroscopy, Franz/enhancer cell diffusion studies), pharmaceutical packaging, process development, ICH-compliant stability testing, microbiology, and clinical trial supplies manufacturing from 0.3 kg batch sizes. Commercial manufacturing spans semi-solids and liquids plus a dedicated cGMP aerosol facility, with batch capabilities from 1 kg to 25,000 kg and serialization-ready infrastructure across operations. Specialized handling suites support DEA-controlled substances, hormones, and light-sensitive materials, and the company performs site and technology transfers including analytical method transfer/validation.

DPT generates revenue through quote-based, project-scoped CDMO engagements with pharmaceutical companies across therapeutic areas including dermatology, gastroenterology, pain management, pulmonary, and women's health. Go-to-market is direct enterprise sales via inbound inquiry, phone, and major pharmaceutical industry conferences such as CPHI Milan 2026, supplemented by technical content marketing via white papers and brochures. Customers range from early-stage development programs through commercial launch, with custom pricing depending on dosage-form complexity, batch size, and service scope. Revenue figures are not publicly disclosed.

Name

DPT Laboratories

Legal name

DPT Laboratories, Ltd.

Website

https://dptlabs.com

Company type

Private

Founded year

1938

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

DPT Laboratories is a Texas-based CDMO, founded in 1938 and a wholly-owned subsidiary of Viatris Inc., specializing in semi-solid and liquid pharmaceutical dosage forms from pre-formulation through commercial-scale cGMP manufacturing for pharmaceutical companies across multiple therapeutic areas.

Ownership category

akta.pro rank

Product category

Pharmaceutical Contract Development and Manufacturing (CDMO)

NAICS

Pharmaceutical Preparation Manufacturing (325412), Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715), Scientific Research and Development Services (5417)

SIC

Pharmaceutical Preparations (2834), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Drug Substance–Drug Product Integrated CDMO (HLAGABAG)

akta.pro secondary industries

Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO (HLAGABAB), Process Development & Tech Transfer Services (CDMO) (HLAGABAL), Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK), CMC & Pharmaceutical Development (Formulation/Process/Analytical Development) (HLAIALAD)

Keywords

• Contract development manufacturing
• Semi-solid dosage forms
• Pharmaceutical CDMO
• CGMP manufacturing
• Aerosol manufacturing

Headquarters

HQ city

San Antonio

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. CDMO Contract Manufacturing Services: DPT generates revenue through contract development and manufacturing organization (CDMO) services for pharmaceutical companies. Services span from pre-formulation through commercial-scale cGMP manufacturing of semi-solid and liquid dosage forms, including clinical trial materials, technology transfers, and analytical services.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

DPT Laboratories is a pharmaceutical contract development and manufacturing organization (CDMO) that specializes exclusively in semi-solid and liquid dosage forms. The company delivers fully integrated services spanning pre-formulation, drug formulation, analytical development, packaging, process development, stability testing, microbiology, clinical trial supplies, and commercial-scale cGMP manufacturing of aerosols, creams, emulsions, gels, lotions, ointments, solutions, and suspensions for pharmaceutical clients.

Product overview

DPT Laboratories is a contract development and manufacturing organization (CDMO) specializing in semi-solid and liquid dosage forms, offering fully integrated services from pre-formulation through commercial-scale cGMP manufacturing. The company's portfolio includes development services (Pre-Formulation, Drug Formulation, Analytical Development, Pharmaceutical Packaging, Process Development, Stability Testing, Microbiology, and Clinical Trial Supplies) and manufacturing services (Semi-Solids and Liquids Manufacturing, Aerosol Foams and Sprays Manufacturing, and Site/Technology Transfers). DPT supports dosage forms including aerosols, creams, emulsions, gels, lotions, ointments, solutions, and suspensions across therapeutic areas such as dermatology, gastroenterology, pain management, and respiratory diseases. The company provides supporting technical resources including white papers and sales brochures.

Differentiator

Problem solved

Functional benefit

Products and services

• Pre-Formulation Services Early-stage API characterization services for pharmaceutical clients including raw material sourcing, solubility profiles, partition coefficient analysis, API-excipient compatibility testing, and analytical method development.
• Drug Formulation Services Pharmaceutical formulation development for semi-solid and liquid dosage forms including particle size analysis (dry, wet, and sprays), rheology/viscosity testing, pH measurement, specific gravity, and informal stability testing.
• Analytical Development Services Analytical method development and validation for small molecules, peptides, and proteins, including stability assays, diffusion studies (Franz cell, enhancer cell), chromatography (HPLC, UPLC, GC/MS, LC/MS/MS), and spectroscopy (UV-Vis, IR).
• Pharmaceutical Packaging Services Drug packaging solutions including packaging specification development, drug-package compatibility assessment, primary container evaluation, container closure compatibility testing, and packaging equipment sourcing.
• Process Development Services Scalable formulation development services from early pilot studies through clinical trial supplies to technology transfer and commercial launch, including process identification, evaluation, selection, and optimization.
• Stability Testing Services Stability studies compliant with ICH standards and custom conditions, covering physical, chemical, and microbiological stability testing, freeze/thaw studies, photostability, and bulk hold testing.
• Microbiology Laboratory Services Full-service microbiology laboratory including microbial limit testing, antimicrobial effectiveness testing (AET), bacterial endotoxin testing (gel clot method), process/USP purified water testing, and environmental monitoring.
• Clinical Trial Supplies cGMP production of clinical trial materials from 0.3 kg batch sizes, supporting Phase I-III clinical materials with extensive packaging capabilities and technology transfers for registration batches.
• Semi-Solids and Liquids Manufacturing Commercial-scale cGMP manufacturing of semi-solid and liquid dosage forms (creams, emulsions, gels, lotions, ointments, solutions, suspensions) with batch sizes from 1 kg to 25,000 kg, including advanced fill and finish capabilities.
• Aerosol Foams and Sprays Manufacturing cGMP manufacturing of aerosol formulations in a dedicated facility with batch sizes from 1 kg to 25,000 kg, supporting pilot to clinical to commercial scale filling, with extensive canister/bottle sizes, valve configurations, and propellant options.
• Site and Technology Transfers Technology transfer services for formulation optimization, pilot to commercial-scale cGMP manufacturing, analytical method assessment/transfer/validation, and process evaluation and optimization. DPT is serialization-ready across these operations.

Quantifiable outcome

• Seamless transition from clinical trial materials to commercial-scale production through integrated CDMO services
• +1 more outcomes

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators4 records

Recent moves5 records

Expansion highlights4 records

Market position

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DPT Laboratories